Astrazeneca Pharma India Ltd Q2 FY2024-2025 Results: Summary
Revenue | ₹416.15Cr |
Net Profits | ₹38.43Cr |
Net Profit Margins | 9.23% |
Highlights
Revenue:
Astrazeneca Pharma India Ltd’s revenue jumped 23.9% since last year same period to ₹416.15Cr in the Q2 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 5.12% jump in its revenue since last 3-months.
Net Profits:
Astrazeneca Pharma India Ltd’s net profit fell -26.62% since last year same period to ₹38.43Cr in the Q2 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 425.95% jump in its net profits since last 3-months.
Net Profit Margins:
Astrazeneca Pharma India Ltd’s net profit margin fell -40.77% since last year same period to 9.23% in the Q2 2024-2025. On a quarterly growth basis, Astrazeneca Pharma India Ltd has generated 410.07% jump in its net profit margins since last 3-months.
